Current News Myosin Therapeutics raises seed round to advance treatments for glioblastoma and stimulant use disorder Posted on March 16, 2023March 16, 2023 by Cort Meyerson 16 Mar Cort Meyerson Shiru Launches OleoPro™, a protein-based alternative fat ingredient C2i Genomics collaborates with Riken Genesis to make AI-powered cancer detection technology “C2inform MRD” available across Japan
